Literature DB >> 2436876

Delayed visual evoked potentials are independent of pattern orientation in macular disease.

I Bodis-Wollner, R G Feldman, S L Guillory, L Mylin.   

Abstract

Visual evoked potentials (VEPs) and contrast sensitivity (CS) were studied in patients affected by maculopathy. VEP delays and CS reduction were demonstrated in each affected eye. In distinction to patients affected by multiple sclerosis (MS), in maculopathy patients VEP latency is independent of the orientation of the grating stimulus. It is proposed that stimulating with more than one pattern orientation is useful in the differential diagnostic use of VEPs.

Entities:  

Mesh:

Year:  1987        PMID: 2436876     DOI: 10.1016/0168-5597(87)90024-4

Source DB:  PubMed          Journal:  Electroencephalogr Clin Neurophysiol        ISSN: 0013-4694


  5 in total

1.  Retinal origin of VECP delays as revealed by simultaneously recorded ERG to patterned stimuli.

Authors:  R Lorenz; W Heider
Journal:  Doc Ophthalmol       Date:  1990-08       Impact factor: 2.379

2.  Electrophysiological testing of visual function after mirror telescope implantation: a case report.

Authors:  Jan Kremláček; Naďa Jirásková; Jana Nekolová; Radovan Šikl; Miroslav Kuba
Journal:  Doc Ophthalmol       Date:  2016-11-10       Impact factor: 2.379

3.  Visual evoked cortical potential can be used to differentiate between uncorrected refractive error and macular disorders.

Authors:  I Perlman; E Segev; N Mazawi; T Merhav-Armon; B Lei; R Leibu
Journal:  Doc Ophthalmol       Date:  2001-01       Impact factor: 2.379

4.  ERGs, cone-isolating VEPs and analytical techniques in children with cone dysfunction syndromes.

Authors:  John P Kelly; Michael A Crognale; Avery H Weiss
Journal:  Doc Ophthalmol       Date:  2003-05       Impact factor: 2.379

Review 5.  Pfiesteria: review of the science and identification of research gaps. Report for the National Center for Environmental Health, Centers for Disease Control and Prevention.

Authors:  J Samet; G S Bignami; R Feldman; W Hawkins; J Neff; T Smayda
Journal:  Environ Health Perspect       Date:  2001-10       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.